Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-acting aripiprazole effects on myelination and cognition in first-episode schizophrenia
2021-004404-18Phase 4Completed
- Sponsor
- IRCCS Fondazione Ca’ Granda Ospedale Maggiore Policlinico
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of aripiprazole in schizophrenia, sponsored by IRCCS Fondazione Ca’ Granda Ospedale Maggiore Policlinico. Started Oct 2021; status: completed.
02
Drugs
aripiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2021-004404-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-004404-18.